Buy Johnson & Johnson (JNJ) Stock for Higher Highs?

Core Viewpoint - The market is experiencing a sell-off due to tariff implications and rising geopolitical tensions, yet stocks like Johnson & Johnson (JNJ), Eli Lilly (LLY), and Pfizer (PFE) are standing out as potential investment opportunities [1]. Group 1: Johnson & Johnson (JNJ) Valuation - JNJ is currently trading below its decade-long median of 16.4X forward earnings, with a peak of 20.1X over the last 10 years [2]. - The stock has a beta ratio of 0.47, indicating it is less volatile than the market benchmark [2]. Group 2: Investment Outlook - JNJ stock has a Zacks Rank of 3 (Hold) after a significant year-to-date rally, suggesting that while there may be better buying opportunities near 52-week peaks, further price increases are possible [3]. - The company is viewed as a hedge against recent market volatility due to its steady growth and reasonable valuation [3].